Shuttle Pharmaceuticals Holdings Inc (SHPH)

Jan 29, 2025

Shuttle Pharmaceuticals expands glioblastoma trial - MSN

Jan 29, 2025

Jan 24, 2025

Form 424B3 Shuttle Pharmaceuticals - StreetInsider.com

Jan 24, 2025

Jan 23, 2025

BlackRock MuniHoldings New York Quality Fund Enters Standstill Agreement with Saba Capital Management - Defense World

Jan 23, 2025

Jan 23, 2025

Shuttle Pharmaceuticals Hits Milestone in Patient Enrollment for Phase 2 Clinical Trial - Defense World

Jan 23, 2025

Jan 22, 2025

Shuttle Pharma hits 25% mark in glioblastoma trial - MSN

Jan 22, 2025

Jan 21, 2025

Shuttle Pharma Reaches Milestone in Patient Enrollment for - GlobeNewswire

Jan 21, 2025

Jan 21, 2025

Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma - Marketscreener.com

Jan 21, 2025

Jan 21, 2025

Shuttle Pharma Hits 25% Enrollment in Phase 2 Glioblastoma Trial for Promising Radiation Drug - StockTitan

Jan 21, 2025

Jan 15, 2025

Form S-1 Shuttle Pharmaceuticals - StreetInsider.com

Jan 15, 2025

Jan 09, 2025

Shuttle Pharmaceuticals (NASDAQ:SHPH) Faces Potential Delisting from Nasdaq due to Minimum Bid Price Requirement Noncompliance - Defense World

Jan 09, 2025

Jan 08, 2025

Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews

Jan 08, 2025

Jan 07, 2025

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - The Manila Times

Jan 07, 2025

Jan 07, 2025

Shuttle Pharmaceuticals CEO to Present Glioblastoma Trial Updates at Lytham Partners Healthcare Summit - StockTitan

Jan 07, 2025

Dec 31, 2024

Tilray (TLRY) Stock Drops 5.11% Amidst Market Volatility - GuruFocus.com

Dec 31, 2024

Dec 21, 2024

EZFill Holdings, Inc. Enters Mobile Fueling Vendor Agreement with Amazon - Defense World

Dec 21, 2024

Dec 21, 2024

Shuttle Pharmaceuticals Holdings, Inc. Engages in Sponsored Research Agreement with UCSF - Defense World

Dec 21, 2024

Dec 19, 2024

Shuttle Pharma Enters into Sponsored Research Agreement - GlobeNewswire

Dec 19, 2024

Dec 19, 2024

Shuttle Pharmaceuticals Partners with UCSF for Breakthrough Prostate Cancer Diagnostic Development - StockTitan

Dec 19, 2024

Dec 17, 2024

Shuttle Pharmaceuticals stock hits 52-week low at $0.67 By Investing.com - Investing.com Canada

Dec 17, 2024

Dec 06, 2024

SHPH stock touches 52-week low at $0.75 amid market challenges - Investing.com UK

Dec 06, 2024

Dec 05, 2024

Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA - GuruFocus.com

Dec 05, 2024

Dec 04, 2024

Likelihood of Approval and Phase Transition Success Rate ModelRopidoxuridine in Bile Duct Cancer (Cholangiocarcinoma) - GlobalData

Dec 04, 2024

Nov 28, 2024

Shuttle Pharmaceuticals Initiates Phase 2 Clinical Trial for Glioblastoma Treatment- - Defense World

Nov 28, 2024

Nov 26, 2024

Shuttle Pharmaceuticals stock hits 52-week low at $0.83 By Investing.com - Investing.com Canada

Nov 26, 2024

Nov 26, 2024

Shuttle Pharma Expands Patient Enrollment for Phase 2 - GlobeNewswire

Nov 26, 2024

Nov 26, 2024

Shuttle Pharmaceuticals Starts Phase 2 Trial for Glioblastoma - TipRanks

Nov 26, 2024

Nov 26, 2024

Shuttle Pharmaceuticals Launches Phase 2 Trial for Breakthrough Glioblastoma Treatment | SHPH Stock News - StockTitan

Nov 26, 2024

Nov 25, 2024

Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Up - GuruFocus.com

Nov 25, 2024

Nov 20, 2024

Micro Cap Company Is Soaring On Phase 2 Trial Update - MSN

Nov 20, 2024

Nov 14, 2024

500: Something went wrong - Investing.com UK

Nov 14, 2024

Nov 14, 2024

Pre-market Movers: ELAB, PHGE, CLDI, BJDX... - RTTNews

Nov 14, 2024

Nov 13, 2024

Shuttle Pharma Provides Third Quarter 2024 Corporate Update - GlobeNewswire

Nov 13, 2024

Nov 13, 2024

Shuttle Pharma Advances Phase 2 Trial, Secures $4.5M Funding for Cancer Treatment Study | SHPH Stock News - StockTitan

Nov 13, 2024

Nov 07, 2024

Shuttle Pharmaceuticals’ $4.5 Million Common Stock Offering - Global Legal Chronicle

Nov 07, 2024

Nov 06, 2024

Top 3 Penny Stocks to Watch Today – October 31, 2024 - The Global Domains News

Nov 06, 2024

Nov 05, 2024

Ironwood Pharmaceuticals (IRWD) Sees Stock Surge Amid Positive A - GuruFocus.com

Nov 05, 2024

Nov 02, 2024

Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination News - MSN

Nov 02, 2024

Nov 01, 2024

Shuttle Pharma Raises $4.5M for Clinical Trials - TipRanks

Nov 01, 2024

Oct 31, 2024

3 Penny Stocks to Watch Now, 10/31/24 - TipRanks

Oct 31, 2024

Oct 31, 2024

Shuttle Pharmaceuticals Successfully Doses First Patients in Phase 2 Clinical Trial for Glioblastoma Treatment - Defense World

Oct 31, 2024

Oct 30, 2024

Shuttle Pharma doses three subjects in Phase II glioblastoma treatment trial - Yahoo! Voices

Oct 30, 2024

Oct 30, 2024

"Stocks Key Trendlines: PRSO, PFIE, SHPH, BKYI, LIXT on the Verge of Breakthroughs" - Marketscreener.com

Oct 30, 2024

Oct 30, 2024

SHPHShuttle Pharmaceuticals Holdings, Inc. Latest Stock News & Market Updates - StockTitan

Oct 30, 2024

Oct 30, 2024

Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 30, 2024

Oct 30, 2024

Shuttle Pharmaceuticals dips 6%, prices $3.5M share offering - MSN

Oct 30, 2024

Oct 29, 2024

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of - GlobeNewswire

Oct 29, 2024

Oct 29, 2024

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - StockTitan

Oct 29, 2024

Oct 29, 2024

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - Benzinga

Oct 29, 2024

Oct 29, 2024

Shuttle Pharma Pays Off Senior Secured Convertible Note - GlobeNewswire

Oct 29, 2024